Annual Total Debt
$14.70 M
-$4.62 M-23.92%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual total debt is $14.70 million, with the most recent change of -$4.62 million (-23.92%) on December 31, 2023.
- During the last 3 years, CUE annual total debt has risen by +$7.55 million (+105.63%).
- CUE annual total debt is now -23.92% below its all-time high of $19.32 million, reached on December 31, 2022.
Performance
CUE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$9.51 M
-$1.75 M-15.55%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly total debt is $9.51 million, with the most recent change of -$1.75 million (-15.55%) on September 30, 2024.
- Over the past year, CUE quarterly total debt has dropped by -$1.75 million (-15.55%).
- CUE quarterly total debt is now -52.46% below its all-time high of $20.01 million, reached on March 31, 2022.
Performance
CUE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
CUE Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.9% | -15.6% |
3 y3 years | +105.6% | -50.8% |
5 y5 years | +100.0% | -50.8% |
CUE Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.9% | +46.2% | -52.5% | at low |
5 y | 5-year | -23.9% | +153.6% | -52.5% | +161.8% |
alltime | all time | -23.9% | -100.0% | -52.5% | -100.0% |
Cue Biopharma Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $9.51 M(-15.5%) |
Jun 2024 | - | $11.26 M(-13.3%) |
Mar 2024 | - | $13.00 M(-11.6%) |
Dec 2023 | $14.70 M(-23.9%) | $14.70 M(-10.3%) |
Sep 2023 | - | $16.38 M(-9.2%) |
Jun 2023 | - | $18.04 M(-3.5%) |
Mar 2023 | - | $18.70 M(-3.2%) |
Dec 2022 | $19.32 M(+92.1%) | $19.32 M(-1.5%) |
Sep 2022 | - | $19.61 M(-1.3%) |
Jun 2022 | - | $19.87 M(-0.7%) |
Mar 2022 | - | $20.01 M(+99.0%) |
Dec 2021 | $10.05 M(+40.7%) | $10.05 M(+176.7%) |
Sep 2021 | - | $3.63 M(-25.5%) |
Jun 2021 | - | $4.87 M(-19.8%) |
Mar 2021 | - | $6.07 M(-15.0%) |
Dec 2020 | $7.15 M | $7.15 M(-12.9%) |
Sep 2020 | - | $8.20 M(-2.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | $8.43 M(+79.0%) |
Mar 2020 | - | $4.71 M(-18.8%) |
Dec 2019 | $5.80 M(>+9900.0%) | $5.80 M(-17.7%) |
Sep 2019 | - | $7.04 M(-10.0%) |
Jun 2019 | - | $7.82 M(-8.9%) |
Mar 2019 | - | $8.59 M(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(-100.0%) |
Mar 2018 | - | $2.31 M(>+9900.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00 |
Dec 2015 | $0.00 | - |
FAQ
- What is Cue Biopharma annual total debt?
- What is the all time high annual total debt for Cue Biopharma?
- What is Cue Biopharma annual total debt year-on-year change?
- What is Cue Biopharma quarterly total debt?
- What is the all time high quarterly total debt for Cue Biopharma?
- What is Cue Biopharma quarterly total debt year-on-year change?
What is Cue Biopharma annual total debt?
The current annual total debt of CUE is $14.70 M
What is the all time high annual total debt for Cue Biopharma?
Cue Biopharma all-time high annual total debt is $19.32 M
What is Cue Biopharma annual total debt year-on-year change?
Over the past year, CUE annual total debt has changed by -$4.62 M (-23.92%)
What is Cue Biopharma quarterly total debt?
The current quarterly total debt of CUE is $9.51 M
What is the all time high quarterly total debt for Cue Biopharma?
Cue Biopharma all-time high quarterly total debt is $20.01 M
What is Cue Biopharma quarterly total debt year-on-year change?
Over the past year, CUE quarterly total debt has changed by -$1.75 M (-15.55%)